France submitted its intention to classify Cannabidiol (CBD) as toxic to reproduction
France intends to classify Cannabidiol (CBD) as Toxic to Reproduction

Date of publication: 07/06/2023

On June 7 2023, the European Chemicals Agency (ECHA) published the intent from France of harmonized classification and labelling (CLH) for CBD, for its reproductive toxic potential. If the process is concluded, CBD would be listed as a carcinogenic, mutagenic and toxic for reproduction (CMR) substance and therefore prohibited in cosmetic products in Europe.

BACKGROUND

Cannabidiol (CBD) (CAS 13956-29-1) is one of many different cannabinoids found and extracted from hemp (Cannabis sativa or Cannabis indica). Cannabidiol is normally located in the aerial parts of the plants (flowers, stems and leaves) and not in the roots or seeds. Although CBD is chemically similar to Tetrahydrocannabinol (THC), Cannabidiol does not cause a psychoactive effect (e.g. euphoric effects). Cannabigerol (CBG), another cannabinoid extracted from the plant, is a precursor molecule that can converted into other cannabinoids (like THC and CBD) during plant growth and is gaining more and more attention by consumers and the cosmetic industry.

Cannabidiol is used in cosmetics and personal care products as an antioxidant, anti-sebum, skin conditioning, and skin-protecting ingredient. It is not currently regulated by the EU Cosmetics Regulation No. 1223/2009, but it is subject to a consultation by the European Commission which issued a call for data on Cannabidiol in cosmetic products at the beginning of June. This call aims to gather scientific information relevant to the safety assessment of Cannabidiol and its potential contaminants, including trans-Δ⁹-tetrahydrocannabinol (THC or delta-9-THC), in pure form or as extracts.

WHAT’S NEW?

On June 7 2023, the European Chemicals Agency (ECHA) published the intent from France of harmonized classification and labelling (CLH) for CBD, for its reproductive toxic potential. If the process is concluded, CBD would be listed as a carcinogenic, mutagenic and toxic for reproduction (CMR) substance and therefore prohibited in cosmetic products in Europe.

WHAT NOW?

When France prepares the dossier for Cannabidiol, it will undergo an acceptance check by ECHA. In case the dossier is accepted, data provided to support the CMR (Carcinogenic, Mutagenic, and Toxic to Reproduction) classification, and specifically the Toxic to Reproduction classification, will undergo an assessment by Risk Assessment Commitee (RAC). The outcome of this assessment might lead to an official CMR classification of Cannabidiol.

Therefore, depending on the outcome of the RAC opinion, the future use of Cannabidiol in cosmetics may face potential threats, because cosmetic ingredients classified as CMR substances, specifically those falling under category 1A or 1B in Part 3 of Annex VI to Regulation (EC) No 1272/2008, are prohibited in cosmetic products. Additionally, cosmetic ingredients classified as CMR substances in category 2 may also face prohibition, unless they have undergone evaluation by the Scientific Committee on Consumer Safety (SCCS) within the new classification framework and have been deemed safe for use in cosmetic products.

References:

European Commission – Call for data on ingredients used in cosmetic products

other REGULATORY UPDATES

SCCS Preliminary Opinion on Sodium Bromothymol Blue (C186) as hair dyeing

Ingredients: SODIUM BROMOTHYMOL BLUE (C186)

Date of publication: 28/10/2022

Following the request from the EU Commission for a scientific opinion on the hair dye Sodium Bromothymol Blue (C186), on October 2022 the Scientific Committee on Consumer Safety (SCCS) issued a preliminary opinion. In light of the data provided, when used in non-oxidative hair colouring products up to a maximum on-head concentration of 0.5%, the SCCS is of the opinion that the complete safety of Sodium Bromothymol Blue could not be assessed.

Read More »

SCCS Final Opinion on the Safety of Triclocarban and Triclosan

Ingredients: TRICLOCARBAN and TRICLOSAN

Date of publication: 25/10/2022

During the plenary meeting on 24-25 October 2022, the Scientific Committee on Consumer Safety (SCCS) presented its final opinion on the safety of Triclocarban and Triclosan as substances with potential endocrine disrupting properties in cosmetic products.

Read More »
Any REGULATORY QUESTION?

Regulation (EU) 2022/692 – OMNIBUS ACT VI – New and Updated Classification of Cosmetic Ingredients

Ingredients: BENZOPHENONE, TEOPHYLLINE, MELAMINE, AZADIRACHTA EXTRACTS, TRIMETHYLOLPROPANE TRIACRYLATE, PENTETIC ACID, PENTASODIUM PENTETATE

Date of publication: 03/05/2022

Date of application: 01/12/2023

The Commission Delegated Regulation (EU) 2022/692 includes new or updated classification for 12 chemicals that may be used as cosmetic ingredients. Seven out of these 12 are now classified as carcinogenic, mutagenic or toxic to reproduction (CMR) and are banned from cosmetic products marketed in the EU.

Read More »

UK Responsible Person Labelling Deadline Extension

RESPONSIBLE PERSON

Date of application: 31/12/2025

The UK Office for Product Safety and Standards (OPSS) have reviewed the requirement to label the product with the UK Responsible Person and have decided to extend this transitional provision for a total period of five years, until 31 December 2025.

Read More »